診断における人工知能のアジア太平洋市場2020-2026:診断種類別(放射線、腫瘍学、神経学、心臓病学、胸部・肺、病理学、その他)、コンポーネント別、地域別

◆英語タイトル:Asia Pacific Artificial Intelligence in Diagnostics Market By Diagnosis Type (Radiology, Oncology, Neurology, Cardiology, Chest & Lungs, Pathology and Other Diagnosis Types), By Component (Services, Software and Hardware), By Country, Industry Analysis and Forecast, 2020 - 2026
◆商品コード:KBV20OCT226
◆発行会社(リサーチ会社):KBV Research
◆発行日:2020年7月31日
◆ページ数:81
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:中国、日本、インド、韓国、シンガポール、マレーシア
◆販売価格オプション(消費税別)
Single User(1名様利用)USD1,500 ⇒換算¥162,000見積依頼/購入/質問フォーム
Global License(法人利用)USD2,520 ⇒換算¥272,160見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はKBV Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
KBV Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本市場調査レポートでは、診断における人工知能のアジア太平洋市場について、市場範囲・調査手法、市場概要、競争分析、診断種類別(放射線、腫瘍学、神経学、心臓病学、胸部・肺、病理学、その他)分析、コンポーネント別分析、地域別分析、企業概要などを総合的、多面的に調査・分析しました。
・市場範囲・調査手法
・市場概要
・競争分析
・診断における人工知能のアジア太平洋市場規模:診断種類別(放射線、腫瘍学、神経学、心臓病学、胸部・肺、病理学、その他)
・診断における人工知能のアジア太平洋市場規模:コンポーネント別
・診断における人工知能のアジア太平洋市場規模:地域別
・企業概要
【レポートの概要】

The Asia Pacific Artificial Intelligence in Diagnostics Market would witness market growth of 29.2% CAGR during the forecast period (2020-2026).

There are already a number of research studies suggesting that AI can perform key health care tasks, such as the diagnosis of disease, as well as or better than humans. Algorithms are now outperforming radiologists in identifying malignant tumours and leading researchers on how to build samples for expensive clinical trials. However, for a number of reasons, we agree that it will be several years before AI substitutes humans across a wide range of medical processes. In this essay, we discuss both the ability of AI to simplify aspects of treatment and some of the obstacles to the rapid introduction of AI in healthcare.

While early attempts to provide diagnosis and care advice have proven difficult, we expect AI to ultimately master this domain as well. Considering the rapid advances in AI for imaging research, it appears likely that most images in radiology and pathology will be analysed by a computer at some point in time. Speech and text recognition have also been used for activities such as patient care and documentation of clinical records, and their use will increase.

The biggest obstacle for AI in these health-care environments is not that innovations can be capable of being effective enough, but instead to ensure that they are implemented in everyday clinical practice. In order for widespread implementation to take place, AI systems must be accepted by regulators, incorporated with EHR systems, adequately standardized to ensure that similar products function in a similar manner, taught to clinicians, paid for by public or private payer organizations, and modified in the field over time. At the end of the day, these challenges will be overcome, but they will take much longer to do so than the technologies themselves will need to mature.

Machine learning has revolutionized our way of life, from language recognition, image processing, handwriting, weather forecasts, and GPS to online search engines. It is now time to focus on successes in machine learning for biological discovery to the benefit of human health. Artificial Intelligence is a subset of computer science that has the ability to interpret complex data. Their potential is to create a consistent relationship with the data collection which can be used in many clinical settings for diagnosis, a treatment which predictive outcomes.

Based on Diagnosis Type, the market is segmented into Radiology, Oncology, Neurology, Cardiology, Chest & Lungs, Pathology and Other Diagnosis Types. Based on Component, the market is segmented into Services, Software and Hardware. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Siemens AG (Siemens Healthineers), Aidoc Medical Ltd., AliveCor, Inc., Imagen Technologies, Inc., VUNO, Inc., IDx Technologies, Inc., NovaSignal Corporation, Riverain Technologies, LLC, and Zebra Medical Vision Ltd.

Scope of the Study
Market Segmentation:

By Diagnosis Type
• Radiology
• Oncology
• Neurology
• Cardiology
• Chest & Lungs
• Pathology and
• Other Diagnosis Types

By Component
• Services
• Software and
• Hardware

By Country
• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Companies Profiled
• General Electric (GE) Co. (GE Healthcare)
• Siemens AG (Siemens Healthineers)
• Aidoc Medical Ltd.
• AliveCor, Inc.
• Imagen Technologies, Inc.
• VUNO, Inc.
• IDx Technologies, Inc.
• NovaSignal Corporation
• Riverain Technologies, LLC
• Zebra Medical Vision Ltd.

Unique Offerings from KBV Research
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

【レポートの目次】

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Artificial Intelligence in Diagnostics Market, by Diagnosis Type
1.4.2 Asia Pacific Artificial Intelligence in Diagnostics Market, by Component
1.4.3 Asia Pacific Artificial Intelligence in Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis – Global
3.1 Recent Industry Wide Strategic Developments
3.1.1 Partnerships, Collaborations and Agreements
3.1.2 Product Launches and Product Expansions
3.1.3 Approvals
3.2 Top Winning Strategies
3.2.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.2.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Nov – 2020, Jun) Leading Players
Chapter 4. Asia Pacific Artificial Intelligence in Diagnostics Market by Diagnosis Type
4.1 Asia Pacific Radiology Market by Country
4.2 Asia Pacific Oncology Market by Country
4.3 Asia Pacific Neurology Market by Country
4.4 Asia Pacific Cardiology Market by Country
4.5 Asia Pacific Chest & Lungs Market by Country
4.6 Asia Pacific Pathology Market by Country
4.7 Asia Pacific Other Diagnosis Types Market by Country
Chapter 5. Asia Pacific Artificial Intelligence in Diagnostics Market by Component
5.1 Asia Pacific Services Market by Country
5.2 Asia Pacific Software Market by Country
5.3 Asia Pacific Hardware Market by Country
Chapter 6. Asia Pacific Artificial Intelligence in Diagnostics Market by Country
6.1 China Artificial Intelligence in Diagnostics Market
6.1.1 China Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.1.2 China Artificial Intelligence in Diagnostics Market by Component
6.2 India Artificial Intelligence in Diagnostics Market
6.2.1 India Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.2.2 India Artificial Intelligence in Diagnostics Market by Component
6.3 Japan Artificial Intelligence in Diagnostics Market
6.3.1 Japan Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.3.2 Japan Artificial Intelligence in Diagnostics Market by Component
6.4 South Korea Artificial Intelligence in Diagnostics Market
6.4.1 South Korea Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.4.2 South Korea Artificial Intelligence in Diagnostics Market by Component
6.5 Singapore Artificial Intelligence in Diagnostics Market
6.5.1 Singapore Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.5.2 Singapore Artificial Intelligence in Diagnostics Market by Component
6.6 Malaysia Artificial Intelligence in Diagnostics Market
6.6.1 Malaysia Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.6.2 Malaysia Artificial Intelligence in Diagnostics Market by Component
6.7 Rest of Asia Pacific Artificial Intelligence in Diagnostics Market
6.7.1 Rest of Asia Pacific Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.7.2 Rest of Asia Pacific Artificial Intelligence in Diagnostics Market by Component
Chapter 7. Company Profiles
7.1 General Electric (GE) Co. (GE Healthcare)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.1.5.3 Approvals:
7.2 Siemens AG (Siemens Healthineers)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Aidoc Medical Ltd.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Product Launches and Product Expansions:
7.3.2.2 Partnerships, Collaborations, and Agreements:
7.4 AliveCor, Inc.
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Partnerships, Collaborations, and Agreements:
7.4.2.2 Product Launches and Product Expansions:
7.5 Imagen Technologies, Inc.
7.5.1 Company Overview
7.6 VUNO, Inc.
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Approvals:
7.7 IDx Technologies, Inc.
7.7.1 Company overview
7.7.2 Recent strategies and developments:
7.7.2.1 Partnerships, Collaborations, and Agreements:
7.8 NovaSignal Corporation
7.8.1 Company Overview
7.9 Riverain Technologies, LLC
7.9.1 Company Overview
7.1 Zebra Medical Vision Ltd.
7.10.1 Company overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
7.10.2.2 Approvals:



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[診断における人工知能のアジア太平洋市場2020-2026:診断種類別(放射線、腫瘍学、神経学、心臓病学、胸部・肺、病理学、その他)、コンポーネント別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆